leisure time -WSS

leisure time

author：knowledge 2025-09-30 00:39:07 - browse：96334

A cloud with a medical folder on the top of an illustration is connected to other medical vectors such as a doctor on a phone screen, a health watch, and a brain chip — coverage from STAT — Adobe

Federal health technology regulators on Wednesday finalized new rules to force software vendors to disclose how artificial intelligence tools are trained, developed, and tested — a move to protect patients against biased and harmful decisions about their care.

The rules are aimed at placing guardrails around a new generation of AI models gaining rapid adoption in hospitals and clinics around the country. These tools are meant to help predict health risks and emergent medical problems, but little is publicly known about their effectiveness, reliability, or fairness.

Starting in 2025, electronic health record vendors who develop or supply these tools, which increasingly use a type of AI known as machine learning, will be required to disclose more technical information to clinical users about their performance and testing, as well as the steps taken to manage potential risks.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： Syphilis numbers in the United States reach record heights

WSS

Archived: an online chat discussing Ebola, vaccines, and a new epidemic

Vertex cell therapy lets patients with type 1 diabetes stop insulin

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

Venture capital firm's plans to take over Akron hospital face hurdles

Venture capital firm's plans to take over Akron hospital face hurdles

Hubble vs. James Webb telescope images: See the difference

knowledge

leisure time

leisure time

State Dept. review finds Biden bears some blame for Afghanistan failures

Readout Newsletter: Vertex, Pfizer, Kura, and other biotech news

Tori Bowie and the unacceptable rates of Black maternal death

Boston competes with Raleigh

New air purifier tech could be key to improving indoor air quality

Merck CEO won’t testify in Senate, citing no expertise in drug prices

Malaria cases in Florida and Texas: Here’s what you need to know

UpToDate has a racism problem: Dr. Stanley Goldfarb

Apple is now the first public company to be valued at $3 trillion

Crowdfunding for unproven stem cell procedures spreads misinformation

focus

Syphilis numbers in the United States reach record heights

The latest on Bluebird gene therapies, Vertex's pain drug, and ADC FOMO

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

Vertex cell therapy lets patients with type 1 diabetes stop insulin

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

The latest on Bluebird gene therapies, Vertex's pain drug, and ADC FOMO

hotspot

focus

hotspot

hotspot